000 | 01650 a2200433 4500 | ||
---|---|---|---|
005 | 20250513185500.0 | ||
264 | 0 | _c19990720 | |
008 | 199907s 0 0 eng d | ||
022 | _a0041-1337 | ||
024 | 7 |
_a10.1097/00007890-199906270-00007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSimonson, M S | |
245 | 0 | 0 |
_aInhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts. _h[electronic resource] |
260 |
_bTransplantation _cJun 1999 |
||
300 |
_a1542-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
650 | 0 | 4 |
_aEndothelin-1 _xblood |
650 | 0 | 4 | _aEndothelin-Converting Enzymes |
650 | 0 | 4 |
_aGlycopeptides _xpharmacology |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
650 | 0 | 4 |
_aMacrophages _xchemistry |
650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtease Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 |
_aTransplantation, Homologous _xpathology |
650 | 0 | 4 |
_aVascular Diseases _xetiology |
700 | 1 | _aHerman, W H | |
700 | 1 | _aRobinson, A | |
700 | 1 | _aSchulak, J | |
700 | 1 | _aHricik, D E | |
773 | 0 |
_tTransplantation _gvol. 67 _gno. 12 _gp. 1542-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-199906270-00007 _zAvailable from publisher's website |
999 |
_c10359990 _d10359990 |